This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations of Su-Ha Park in Pharmaceutical Chemistry
Introduction
Su-Ha Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has led to the creation of a unique salt of tenofovir disoproxil, which has potential applications in medicine.
Latest Patents
Su-Ha Park holds 1 patent for his invention titled "Salt of tenofovir disoproxil." This patent discloses a novel tenofovir disoproxil edisylate salt characterized by a specific chemical structure. This innovation is expected to enhance the efficacy of tenofovir disoproxil in therapeutic applications.
Career Highlights
Su-Ha Park is currently employed at Jw Pharmaceutical Corporation, where he continues to engage in groundbreaking research. His work at the company has positioned him as a key player in the development of new pharmaceutical products. His expertise in chemical formulations has been instrumental in advancing the company's research initiatives.
Collaborations
Su-Ha Park collaborates with talented colleagues, including Do-Kyu Pyun and Won-Kyoung Lee. These partnerships foster a dynamic research environment that encourages innovation and the sharing of ideas.
Conclusion
Su-Ha Park's contributions to pharmaceutical chemistry, particularly through his patent on tenofovir disoproxil, highlight his role as an influential inventor. His ongoing work at Jw Pharmaceutical Corporation promises to yield further advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile